Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

430 trials with published results (16%)

Research Maturity

2176 completed trials (79% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

4.4%

121 terminated out of 2759 trials

Success Rate

94.7%

+8.2% vs benchmark

Late-Stage Pipeline

3%

87 trials in Phase 3/4

Results Transparency

20%

430 of 2176 completed with results

Key Signals

430 with results95% success121 terminated

Data Visualizations

Phase Distribution

2,553Total
Not Applicable (528)
Early P 1 (42)
P 1 (1836)
P 2 (60)
P 3 (34)
P 4 (53)

Trial Status

Completed2,176
Recruiting184
Terminated121
Unknown116
Not Yet Recruiting64
Withdrawn45

Trial Success Rate

94.7%

Benchmark: 86.5%

Based on 2176 completed trials

Clinical Trials (2759)

Showing 20 of 20 trials
NCT06577454Not ApplicableSuspended

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

NCT07223450Phase 1Completed

A Study on Oral and Intranasal Forms of Oxycodone in Healthy Volunteers Using Pharmacokinetic Modeling

NCT07570186Phase 1Not Yet RecruitingPrimary

Food and Ethnicity Effects on Pharmacokinetics and Safety of JPI-547 in Healthy Male Participants

NCT07015840Not ApplicableRecruiting

Generalization and Specificity of Visual Learning During Sleep

NCT04657042RecruitingPrimary

4D-MRI for Precision Medicine

NCT06868914Phase 1Not Yet RecruitingPrimary

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

NCT07446400Phase 1RecruitingPrimary

A Trial to Examine the Interaction of Repinatrabit With Ethinyl Estradiol/Norethindrone, Metformin,Carbamazepine, Rosuvastatin, and Methotrexate When Administered Together

NCT07570082Phase 1RecruitingPrimary

Drug-Drug Interaction Study of Atumelnant in Healthy Participants

NCT07570992Phase 1Not Yet RecruitingPrimary

A Research Study to Evaluate the Safety of NNC1679-0001 When Given to Healthy Participants and Participants With T2DM

NCT07567781Phase 1RecruitingPrimary

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

NCT01237093Phase 1Completed

Developing Biomarkers of Dietary Intake

NCT07113106Phase 1Active Not RecruitingPrimary

Dose Escalation Trial of CD40.Pan.CoV Vaccine, Adjuvanted or Not, as a Booster in Adult Healthy Volunteers

NCT05799274Phase 1RecruitingPrimary

Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors

NCT06766929Phase 1Active Not RecruitingPrimary

A Phase I Clinical Study of VSA012 in Healthy Volunteers

NCT07566130Phase 1Active Not RecruitingPrimary

A Study to Assess Adverse Events, Tolerability and How Single and Ascending Oral Doses of Nacresertib Move Through the Body In Healthy Adult Participants

NCT00410241Active Not RecruitingPrimary

ClinSeq: A Large-Scale Medical Sequencing Clinical Research Pilot Study

NCT07565792Phase 1Not Yet RecruitingPrimary

Study of Food Effects of VV913 Capsules in Chinese Healthy Volunteers

NCT07231679Phase 1RecruitingPrimary

A Study to Investigate IGT-303 in Healthy Volunteers and Participants With Chronic Kidney Disease

NCT07565064Enrolling By Invitation

ALPCO 25(OH) Vitamin D CLIA Kit - Fresh Versus Frozen Serum and Plasma Stability Study

NCT07556744Not ApplicableNot Yet Recruiting

SOMA Validation RCT: Testing Structural Equivalence and Mechanistic Orthogonality of an Open-Source Mindfulness Stimulus Library

Scroll to load more

Research Network

Activity Timeline